Epidemiology of Acute Heart Failure in Critically Ill Patients With COVID-19: An Analysis From the Critical Care Cardiology Trials NetworkCOVID-19가 있는 중환자의 급성 심부전 역학: Critical Care Cardiology Trials Network의 분석Article Published on 2022-04-012022-09-11 Journal: Journal of cardiac failure [Category] 바이오마커, 임상, [키워드] absence Activation Acute heart failure Admission assessment Biomarker Biomarkers biomarkers of inflammation cardiac troponin Cardiogenic shock Cardiology classic clinical Clinical features coronavirus disease Coronavirus disease 2019 COVID-19 Critically ill de novo evaluated failure Features heart heart failure hemodynamic highest ICU Ill Illness severity Inflammatory intensive care majority median mortality rate mortality rates myocardial injury network outcome Patient peptide profile Shock Stress troponin with COVID-19 [DOI] 10.1016/j.cardfail.2021.12.020 PMC 바로가기 [Article Type] Article
Differences and Similarities Among COVID-19 Patients Treated in Seven ICUs in Three Countries Within One Region: An Observational Cohort StudyObservational Study Published on 2022-04-012022-10-05 Journal: Critical Care Medicine [Category] 임상, [키워드] Admission admitted to ICU age Analysis applied approval assessment Belgium Characteristics chronic Clinical characteristics Comorbidities complications coronavirus disease COVID-19 COVID-19 patient criteria Descriptive statistics Diagnosis difference disease severity driver European failure female Frequency Genetic Germany healthcare Healthcare system ICU independent interfere International Laboratory Logistic regression measurement Mortality mortality rate Netherlands Observational cohort study organ support outcome pandemic Patient patient group performed Physiology retrieved Sex significantly Support supported Therapies therapy variance Variation [DOI] 10.1097/CCM.0000000000005314 PMC 바로가기 [Article Type] Observational Study
Cardiac And Inflammatory Biomarkers And New Or Worsening Heart Failure In High-risk Patients With COVID-19Conference abstract Published on 2022-04-012022-10-05 Journal: Journal of cardiac failure [Category] 바이오마커, [키워드] adverse outcome age association average baseline biochemical marker BNP C-reactive protein cardiac Cardiomyopathy cell activation clinical collected condition consequence coronary syndrome COVID-19 Cytokines decrease defined develop Diagnosis discharge dysfunction Ejection fraction elevated enrolled failure Follow-up greater groups heart Hospital admission Hospitalized hsCRP identify IL-6 Immune cell Inflammation Inflammatory biomarker inflammatory biomarkers Inflammatory marker interleukin-6 interquartile range IQR Ischemia male management measure mechanism median multifactorial myocardial injury myocarditis New no significant difference Patient peptide performed plasma pro-inflammatory cytokine storm profile prospective cohort study quantification reported Result risk factor sensitivity serum specimen Subtypes syndrome Trigger troponin levels ventricular with COVID-19 worsening [DOI] 10.1016/j.cardfail.2022.03.243 [Article Type] Conference abstract
Use of Airway Pressure Release Ventilation in Patients With Acute Respiratory Failure Due to COVID-19: Results of a Single-Center Randomized Controlled TrialRandomized Controlled Trial Published on 2022-04-012022-10-05 Journal: Critical Care Medicine [Category] 임상, [키워드] 48 hour acute respiratory distress Airway Pressure Care characterized clinical evidence Controlled coronavirus disease defined Diagnosis expiratory failure greater group groups ICU intubated patient intubation less management mandatory mean difference measurement Mortality no difference outcome Patient pressure Randomized Randomized controlled trial receive recent Release respiratory Result severe coronavirus disease static compliance syndrome Ventilation ventilator-free day ventilatory Volume [DOI] 10.1097/CCM.0000000000005312 PMC 바로가기 [Article Type] Randomized Controlled Trial
Interim analysis of the COSA (COVID-19 patients treated with the Seraph® 100 Microbind® Affinity filter) registryCOSA(Seraph® 100 Microbind® Affinity 필터로 치료한 코로나19 환자) 레지스트리의 중간 분석Article Published on 2022-03-252022-09-11 Journal: Nephrology, dialysis, transplantation : official p [Category] SARS, 치료법, [키워드] 30-day mortality rate acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Adverse adverse events adverse outcome adverse outcomes affinity Analysis assessment authorization average bacterial superinfection Blood Characteristics clinical Complete coronavirus coronavirus disease Coronavirus disease 2019 correlated country COVID COVID-19 COVID-19 patient COVID-19 patients Cox regression demonstrated Device died drug Efficacy Emergency Emergency use authorization evaluate event extracorporeal treatment failure failure rate FDA ferritin ferritin levels Filter Follow-up food Food and Drug Administration hospital ICU ICU admission ICU patient ICU Patients intensive care Interim kidney median Mortality mortality rate multivariate multivariate Cox regression non-ICU non-ICU patients nucleocapsid outcome parameter Pathogens Patient patients patients treated performed predicted Premature reduction registry removal replacement therapy reported representing SARS-CoV-2 SARS-CoV-2 virus Seraph severe acute respiratory syndrome Coronavirus severe coronavirus disease shown SOFA SOFA scores Symptoms the SARS-CoV-2 virus therapy treated Treatment treatment for COVID-19 treatment of COVID-19 Viraemia Viral load viruses were excluded while [DOI] 10.1093/ndt/gfab347 PMC 바로가기 [Article Type] Article
Longitudinal profile of antibody response to SARS-CoV-2 in patients with COVID-19 in a setting from Sub-Saharan Africa: A prospective longitudinal study사하라 사막 이남 아프리카의 상황에서 COVID-19 환자의 SARS-CoV-2에 대한 항체 반응의 종단 프로필: 전향적 종단 연구Article Published on 2022-03-232022-09-11 Journal: PLoS ONE [Category] MERS, SARS, 진단, 치료기술, [키워드] African agreement antibody Antibody Response asymptomatic patient asymptomatic patients Cohort collected comprehensive evaluation COVID-19 cases COVID-19 patient detectable diagnosis of COVID-19 enrolled Enrollment epidemiological studies Factor failure Follow-up heterogeneous responses IgG IgM immunoassay implementation increase increases in lateral flow LFIAs longitudinal Longitudinal assessment median median time no difference NPV onset of symptoms Patient patients with COVID-19 PCR-confirmed COVID-19 patient plasma sample plasma samples positive Positive predictive value PPV Predictive value Prospective Study ranged reached reduced Research SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody scenario Seroconversion seroconversion time seroconvert seroconverted Serological testing serology Seroprevalence significantly specificity symptom onset symptomatic case symptomatic cases tested vaccine responses [DOI] 10.1371/journal.pone.0263627 PMC 바로가기 [Article Type] Article
Case Report: Severe Rhabdomyolysis and Multiorgan Failure After ChAdOx1 nCoV-19 Vaccination증례 보고서: ChAdOx1 nCoV-19 백신 접종 후 심각한 횡문근 융해증 및 다기관 부전Case Reports Published on 2022-03-172022-09-12 Journal: Frontiers in Immunology [Category] MERS, SARS, 진단, [키워드] accelerated Anakinra assumption biologic Bone marrow Case report ChAdOx1 ChAdOx1 nCoV-19 characterized creatine phosphokinase cytokine Cytokine storm Deterioration dramatic increase drug eculizumab failure first dose had no healthy hypoglycemia immunosuppressive Infection inflammatory markers kidney liver lung multi organ failure nine occur occurred patient death patients with SARS-CoV-2 PCT physician procalcitonin rapid increase reported resulting rhabdomyolysis Risk factors SARS-CoV-2 SARS-CoV2 Shock Skeletal muscle Steroids therapy Treatment vaccination vaccine administration [DOI] 10.3389/fimmu.2022.845496 PMC 바로가기 [Article Type] Case Reports
Impact of the COVID-19 Pandemic on Patients Without COVID-19 With Acute Myocardial Infarction and Heart FailureObservational Study Published on 2022-03-152022-10-05 Journal: Journal of the American Heart Association [Category] 임상, [키워드] 95% CI Acuity Acute myocardial infarction age analyzed both groups cardiovascular cardiovascular disease Care catheterization changes in Comorbidities Comorbidity COVID-19 COVID-19 pandemic COVID‐19 excess mortality failure health system heart heart failure hospital Hospitalization hospitalizations Impact In-hospital include left heart catheterization mechanism Mortality Myocardial Myocardial infarction no difference Odds ratio outcome Patient proportion reported Result Sex spillover strain Treatment Variation Volume [DOI] 10.1161/JAHA.121.022625 PMC 바로가기 [Article Type] Observational Study
The Effects of Enteral Nutrition in Critically Ill Patients with COVID-19: A Systematic Review and Meta-AnalysisReview Published on 2022-03-072022-10-31 Journal: Nutrients [Category] COVID-19, MERS, SARS, [키워드] 95% CI Analysis article articles assessment conducted COVID-19 Critically ill Critically ill patient database days on mechanical ventilation delayed enteral nutrition early enteral nutrition Effect effective Enteral enteral nutrition evaluate the effect failure gastrointestinal intolerance Google Scholar Hospital stay ICU Ill Inflammation intestinal mucosa Length of hospital stay Malnutrition Meta-analysis Mortality no significant difference not significant nutrition on mechanical ventilation parenteral nutrition Patient patients patients with COVID-19 PICO Protein reduce reduced reducing reduction in reductions in relative review risk searched significant increase significantly SOFA Stress Support systematic review with COVID-19 [DOI] 10.3390/nu14051120 PMC 바로가기 [Article Type] Review
Global COVID-19 Vaccine Inequity: Failures in the First Year of Distribution and Potential Solutions for the Future글로벌 코로나19 백신 불평등: 유통 첫 해의 실패와 미래를 위한 잠재적 솔루션Article Published on 2022-03-072022-09-11 Journal: Frontiers in Public Health [Category] SARS, 변종, [키워드] Affect approach benefit country COVAX COVID-19 COVID-19 vaccine COVID-19 vaccines D develop distribution effective European country facilitate failure Future global pandemic Health Organization herd immunity Host Immunity include inequality intellectual property interface International international cooperation Investment knowledge majority manufacturing—R& not effective pandemic Pharmaceutical Company pharmaceutical industry Potential pricing resulting risk SARS-CoV-2 pandemic solution Support Technology transfer the SARS-CoV-2 transfer vaccination rate vaccination rates Vaccine Vaccines variant World Health Organization Year [DOI] 10.3389/fpubh.2022.821117 PMC 바로가기 [Article Type] Article